Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health.

I'm Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement,

and a former health commissioner here in Baltimore.

Our goal is to bring evidence and experience to illuminate critical public health issues.

If you have questions or ideas for us, please send an email to public health question at jhh.edu.

That's public health question at jhu.edu for future podcast episodes.

Hey listeners, it's Lindsay Smith-Rogers, producer of public health on call, and we want to hear from you.

In more than 500 episodes since March 2020, we've been bringing you the latest on urgent

public health topics like COVID-19, climate change, gun violence, monkeypox, racism, and more.

We'll continue to cover these, but we'd like to know what other public health topics

would you like to hear more about. Plus, you can enter to win some amazing podcast swag,

including the Beach Toat, featured on our Twitter account. Please go to publichealth.j.j.u.edu slash public health on call slash survey to take a

brief survey of potential future topics. This will be open until September 9th, and that link is

publichealth.j.j.u.edu slash public health on call slash survey. We're excited to hear from you,

and thank you so much for listening. Hi, I'm Lindsay Smith-Rogers, producer of public health on call.

Today, Stephanie Desmond talks to Jerry Anderson, a health policy expert at Johns Hopkins,

who has spent decades working

on Medicare issues, including the incredibly high price of prescription drugs. They discuss the

changes coming to drug pricing as a result of the recent Inflation Reduction Act signed into law

by President Biden. Let's listen. Jerry Anderson, thanks so much for joining me.

Well, thank you for having me to come here.

Jerry, you are an expert on drug pricing, and that's why I brought you here today.

...